Physician profile
Stephanie Gianoukos
NPI 1497990485
$4,001.64
in general payments reported to CMS, 2019-2025
16 companies · $371 in 2025
The $371 reported for 2025 was more than what 89% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $736 · 2020: $140 · 2021: $185 · 2022: $452 · 2023: $1,924 · 2024: $193 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363 · Travel and Lodging: $625 · Consulting Fee: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,362.89 |
| Travel and Lodging | $624.73 |
| Consulting Fee | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,631.79 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Boston Scientific Corporation | $908.73 | 2019-2025 | Intracept, Superion Indirect Decompression System |
| Hydrocision, INC. | $500.00 | 2023 | Tenjet |
| Medtronic USA, INC. | $313.21 | 2019-2020 | |
| Stryker Corporation | $160.27 | 2025 | Mild Device Kit |
| Bioventus LLC | $158.94 | 2023 | Stimrouter Implantable Kit |
| Novartis Pharmaceuticals Corporation | $48.73 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $44.19 | 2019 | |
| Depuy Synthes Sales INC. | $40.75 | 2023-2024 | Monovisc, Orthovisc |
| Abbott Laboratories | $39.60 | 2021-2024 | Eterna |
| Si-Bone, INC. | $30.33 | 2020 | |
| Globus Medical, INC. | $30.16 | 2025 | Senza |
| Stimwave Technologies Incorporated | $29.84 | 2019 | |
| Pfizer INC. | $25.83 | 2019 | |
| Spinal Simplicity, LLC | $20.52 | 2024 | Ha Minuteman G3-R |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emergent Biosolutions INC. | $18.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Gianoukos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.